Retinal Dystrophies

What are Retinal Dystrophies? 

Retinal dystrophies are a group of inherited eye conditions that affect the retina (the light-sensitive layer at the back of the eye that allows us to see). Over time, these conditions cause the retina to slowly degenerate, leading to gradual vision loss. The changes are usually permanent, but early diagnosis and supportive care can help maintain useful vision for as long as possible.

Causes of Retinal Dystrophy

Retinal dystrophies are primarily caused by genetic mutations that affect how the light-sensing cells of the retina (rods and cones) work. Over time, photoreceptor cells die, followed by secondary degeneration of the retinal pigment epithelium (RPE) and choroid (blood vessel layer). Progressive loss of functional photoreceptors results in gradual visual decline.

Types of Retinal Dystrophy

There are different forms of retinal dystrophy that affect the retina in different ways:

• Rod-cone dystrophies – e.g., Retinitis Pigmentosa (night blindness followed by peripheral vision loss).
• Cone-rod dystrophies – central vision loss with later peripheral involvement.
• Macular dystrophies – e.g., Stargardt disease, Best’s disease, predominantly affecting central retina.
• Choroideremia – progressive loss of retinal and choroidal layers.
• Leber congenital amaurosis (LCA) – severe visual impairment from birth or early infancy.

Risk Factors of Retinal Dystrophy

People with a higher risk of retinal dystrophy include those with:

• Family history of retinal dystrophy
• Parents who are closely related (consanguineous)
• Associated syndromes e.g., Usher syndrome causing retinal dystrophy with hearing loss
• Certain genetic mutations

Symptoms of Retinal Dystrophy

Symptoms vary depending on the type:

Early symptoms:

• Night blindness (nyctalopia) in rod-predominant forms
• Photophobia and color vision defects in cone-predominant forms

Progressive symptoms:

• Difficulty with peripheral vision causing a narrow visual field (tunnel vision)
• Central vision loss (macular involvement)
• Blurred vision
• Reduced contrast sensitivity

Complications of Retinal Dystrophy

Retinal dystrophy can lead to following complications:

• Severe visual field constriction leading to legal blindness
• Secondary glaucoma or cataracts
• Psychosocial impact including depression and reduced independence

Diagnosis of Retinal Dystrophy

Retinal dystrophy can be diagnosed by your eye specialist based on:

• History & examination: Onset, family history, associated systemic features
• Ophthalmic evaluation:
  • Visual acuity testing
  • Visual field analysis
  • Color vision testing
• Imaging & tests:
  • Fundus examination to view the retina
  • Optical coherence tomography (OCT) – retinal layer assessment
  • Fundus autofluorescence (FAF) – RPE changes
  • Electroretinography (ERG) – assesses rod/cone function
• Genetic testing: Confirms diagnosis, guides counseling, and eligibility for gene therapy trials

Management of Retinal Dystrophy

Currently, no definitive cure exists for retinal dystrophy; management aims to slow progression, optimize remaining vision, and improve quality of life.

Supportive measures:

• Low vision aids (magnifiers, electronic devices)
• Orientation and mobility training
• Photoprotective eyewear

Nutritional supplements: In certain cases, antioxidants such as vitamin A (with caution), and omega-3 fatty acids may be recommended.

Medical advances:

• Gene therapy: g., voretigene neparvovec for RPE65-related dystrophy
• Retinal prostheses and stem cell research under investigation
• Treatment of complications: Management of cataract or cystoid macular edema if present
• Genetic counseling: Essential for affected individuals and families

Prognosis of Retinal Dystrophy

The rate of progression varies with the type and genetic basis. Some individuals maintain functional vision into middle age, while others experience profound vision loss in early life. Early diagnosis and adaptive strategies significantly improve functional outcomes.

Prevention of Retinal Dystrophy

No primary prevention is available due to the genetic basis however certain measures include:

• Carrier screening and genetic counseling in high-risk families
• Prenatal and pre-implantation genetic testing in select cases